Showing results (91-100 of 246) with videos related to
Sort By:
Pageof 25
Annals of Internal Medicine|December 7, 2007
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolismJames D Douketis, Chu Shu Gu, Sam Schulman, et al.Journal of Thrombosis and Haemostasis : JTH|March 24, 2020
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysisEmanuele Valeriani, Ettore Porreca, Jeffrey I Weitz, et al.Research and Practice in Thrombosis and Haemostasis|February 28, 2022
Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohortMatteo Candeloro, John W Eikelboom, Noel Chan, et al.Journal of Internal Medicine|August 29, 2023
Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based studyKatarina Glise Sandblad, Sam Schulman, Annika Rosengren, et al.Thrombosis and Haemostasis|April 21, 2017
NOACs for treatment of venous thromboembolism in clinical practiceSam Schulman, Daniel Singer, Walter Ageno, et al.Thrombosis and Haemostasis|December 23, 2016
Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysisAmmar Majeed, Niklas Wallvik, Joakim Eriksson, et al.Clinical Pharmacology and Therapeutics|May 21, 2005
Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosisMarie Cullberg, Ulf G Eriksson, Karin Wåhlander, et al.Annals of Internal Medicine|November 16, 2011
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trialSam Schulman, Sameer Parpia, Clare Stewart, et al.Pharmacotherapy|June 8, 2013
Anticoagulation control with daily low-dose vitamin k to reduce clinically adverse outcomes and international normalized ratio variability: a systematic review and meta-analysisJason Lam, Sam Schulman, Daniel M Witt, et al.Journal of Clinical Pharmacology|January 25, 2007
NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I studyDag Nilsson, Johan Wemer, Yi-Fang Cheng, et al.Pageof 25